Pharma

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

MediGene AG and three private investors have founded Immunocore Ltd, which will focus on the technology platform for monoclonal T-cell receptors (mTCR) of MediGene's UK subsidiary MediGene Ltd. MediGene holds a 38.5% stake in Immunocore Ltd and will be the largest shareholder of the new company.


Previous Article Next Article

Today in Biotechnology...keeping you current

Spherix announces full-scale production of pharmaceutical tagatose
Spherix, 06/24/09

Thermophilic ethanologenesis: future prospects for second-generation bioethanol production
Trends in Biotechnology , 06/30/09

Antiplasmodial activity of extracts from seven medicinal plants used in malaria treatment in Cameroon
Journal of Ethnopharmacology , 06/15/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address